Horizon's Uplizna gets approval in EU to treat nervous system disorder of eye, spine - Seeking Alpha

The European Commission ((EC)) approved Horizon Therapeutics' (HZNP) Uplizna as a standalone therapy for adult patients with neuromyelitis optica spectrum disorder ((NMOSD)) who...

keremberk/iStock Editorial via Getty Images

full article...